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Background: Microvascular obstruction (MVO) at the acute phase of myocardial infarction (MI) is associated with greater myocardial damage, 
left ventricular (LV) impairment and higher mortality. We aimed to evaluate whether a correlation exists between plasma levels of cardiac troponin 
I (cTnI) at the acute phase of MI and the extent of no-reflow as assessed by 3-T cardiac magnetic resonance imaging (MRI). Secondly, we aimed to 
define a cut-off value for cTnI predictive of no-flow. 
Methods: We included 51 consecutive patients with no previous history of cardiovascular disease, and presenting for a first MI with or without ST 
elevation. Infarct size and extent of no-reflow were evaluated by 3-T MRI during the acute phase using early and late hyperenhancement imaging at 3 
and 15 minutes after injection of gadolinium. Extent of no-reflow at 15 minutes (MVO) was measured and correlated with repeat doses of cTnI at 6, 
12, 24, 48 and 72 hours after admission.
Results: Extent of MVO is significantly correlated to area under the curve for cTnI (r=0.55, p<0.02), to the area under the ROC curve (p<0.005). 
After analysis of ROC curves, a cut-off cTnI value >89 ng/mL at 6 hours seems to best predict presence of early MVO with a sensitivity of 63% and 
specificity of 88.2%.
Conclusion: A cut-off value of 89 ng/mL for cTnI seems to best predict presence of MVO, which contributes to unfavourable long-term outcome.
